Virtu Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,185
| Closed | -$16K | – | 2365 |
|
|
2023
Q4 | $16K | Buy |
22,185
+3,466
| +19% | +$2.01K | ﹤0.01% | 1358 |
|
|
2023
Q3 | $13K | Buy |
+18,719
| New | +$23.9K | ﹤0.01% | 1077 |
|
|
2023
Q1 | – | Sell |
-1,427
| Closed | -$17K | – | 2313 |
|
|
2022
Q4 | $17K | Buy |
1,427
+1,056
| +285% | +$12.1K | ﹤0.01% | 1300 |
|
|
2022
Q3 | $5K | Buy |
+371
| New | +$9.6K | ﹤0.01% | 1587 |
|
|
2022
Q1 | – | Sell |
-3,208
| Closed | -$136K | – | 2244 |
|
|
2021
Q4 | $136K | Buy |
3,208
+281
| +10% | +$17.5K | 0.01% | 991 |
|
|
2021
Q3 | $199K | Buy |
+2,927
| New | +$214K | 0.02% | 921 |
|
|
2021
Q2 | – | Sell |
-4,947
| Closed | -$326K | – | 2214 |
|
|
2021
Q1 | $326K | Buy |
+4,947
| New | +$385K | 0.02% | 767 |
|
|
2020
Q4 | – | Sell |
-567
| Closed | -$31K | – | 1896 |
|
|
2020
Q3 | $31K | Buy |
+567
| New | +$33.6K | 0.01% | 884 |
|
|
2019
Q2 | – | Sell |
-294
| Closed | -$43K | – | 1965 |
|
|
2019
Q1 | $43K | Buy |
+294
| New | +$56.8K | ﹤0.01% | 1230 |
|
|
2018
Q3 | – | Sell |
-342
| Closed | -$77K | – | 2354 |
|
|
2018
Q2 | $77K | Buy |
+342
| New | +$91.6K | ﹤0.01% | 1696 |
|
|
2018
Q1 | – | Sell |
-1,434
| Closed | -$442K | – | 2771 |
|
|
2017
Q4 | $442K | Buy |
+1,434
| New | +$472K | 0.02% | 930 |
|
Other funds holding DMK
Virtu Financial's DMK Position: Q1 2024 in Review
Virtu Financial sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 22,185 shares — an estimated $16K sold.
Virtu Financial first reported a position in DMK in Q4 2017 and held it in 11 quarters. The position peaked at $442K in Q4 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Virtu Financial reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Virtu Financial sold 22,185 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $16K.
- Virtu Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 11 quarters.
- Virtu Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $442K in Q4 2017.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.